Symphogen symphogen.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the frontier of antibody discovery by creating well-characterized antibody mixtures that address multiple oncology targets in a single drug product. The company has matured its pipeline, currently has two product candidates in the clinic, and is researching promising novel immuno-oncology opportunities.

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the frontier of antibody discovery by creating well-char...Show all

Company (Alive / Active)

Phone: +45 4526 5050

Fax:

Pederstrupvej 93

Ballerup, DK-2750
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Symphogen $364.2M Nov 30, 2017
Humanetics Corporation $0.6M Oct 10, 2017
PharmAthene $61.2M Mar 14, 2005
See all 19 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Symphogen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors

Competitors

Company Status Description Investors
See all 19 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Humanized pan-her antibody compositions May 02, 2013 Dec 27, 2016 Patent
Anti-her3 antibodies and compositions Oct 31, 2011 Dec 22, 2015 Patent
Method for manufacturing recombinant polyclonal proteins Dec 19, 2008 Oct 20, 2015 Patent
Pan-her antibody composition Nov 01, 2011 Oct 13, 2015 Patent
Methods using recombinant anti-epidermal growth factor receptor antibody compositions Aug 27, 2009 Mar 04, 2014 Patent
See all 16 patents